Boxer Capital, LLC Allakos Inc. Transaction History

Boxer Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$79.58 - $152.45 $53.7 Million - $103 Million	-675,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $6.2 Million - $17.9 Million	200,000 Added 42.11%	675,000 $53.1 Million
Q2 2019 Aug 14, 2019	SELL	$36.0 - $44.73 $11.7 Million - $14.5 Million	-324,000 Reduced 40.55%	475,000 $20.6 Million
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $27 Million - $41.5 Million	799,000 New	799,000 $32.4 Million

104

70.7M

43.8K

1.4K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $54.2M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.